CVS Health Corporation (NYSE:CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here’s what you need to know.
What To Know: CVS Health has appointed four new members to its board including Larry Robbins, Leslie Norwalk, Guy Sansone and Doug Shulman. The appointments come as a result of discussions with activist investor Glenview Capital Management, a major stakeholder.
The new board members bring varied expertise. Norwalk will join the Health Services Committee, Sansone will join the Audit Committee and Shulman will join the Management Planning and Development Committee. Robbins, who is the CEO of Glenview, will also join the board.
CVS Health’s board now consists of 16 members in …
Full story available on Benzinga.com
Related posts:
- United Airlines Gears Up For Q4 Earnings: Investors Brace For Possible Turbulence
- Goldman Sachs Upgrades Fiverr International, Highlights AI-Driven Product Innovation in 2024 As Strong Catalyst
- Rails Back On Track: Analyst Upgrades Union Pacific And Norfolk Southern, Predicts Strong Intermodal Recovery
- Brazil’s PagSeguro Digital Gets A Boost: Goldman Sachs Upgrades Stock, Forecasts Stronger 2024 Growth